All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
LevFin

CVC provides €500m financing with ESG-linked margin ratchet

Pharmaceutical research, conceptual image.

Deal finances Partners' acquisition of Greece's Pharmathen

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree